The Global Coronary Stents Market potential has widened due to recent technological advancements. According to a report published by Fortune Business Insights, titled “Coronary Stents Market Size, Share and Global Trend by Deployment (Self and Balloon-expandable), Stent Type (Drug Eluting Stent, Bioresorbable Stent, Bare Metal Stent, Covered Stent and Others), End User (Hospitals, Ambulatory Surgical Centers, Specialty Clinics, Catheterization Labs) and Geography Forecast till 2025,” the market was valued at US$ 5,244.9 Mn in 2017.
According to Fortune Business Insights, the market will reach US$ 8,414.5 Mn by the end of 2025, exhibiting a CAGR of 6.1%
Browse Complete Report Details @ https://www.fortunebusinessinsights.com/industry-reports/coronary-stents-market-100065
“Some of the Main Key Players Covered in the Report”
- Cardinal Health
- Cook Medical
- C R Bard
- MicroPort Scientific Corp
- Terumo Corporation
- BKK B. Braun Melsungen AG
- Boston Scientific
“Growing Regulatory Approvals Will Lead to Substantial Coronary Stents Market Growth”
The high prevalence of coronary arterial diseases has opened up a huge coronary stents market potential. Resulting from the high demand for coronary stents, several companies have shifted their focus on developing technologically advanced stents with the aim of serving a wider audience.
The coronary stents market trends such as incorporation of micro-sized stents and use of minimally invasive procedures have contributed to the market growth. In recent years, regulatory authorities have eased off on their reluctance to approve coronary stents market products. Abbott’s CE approval for Xience Sierra was a game changer in the coronary stents industry as the device received worldwide allocates for its exceptional functional operations.
By Stent Type
- Drug-Eluting Stent
- Bioresorbable Stent
- Bare Metal Stent
- Covered Stent
- Ambulatory Surgical Centers
- Specialty Clinics
- Catheterization Labs
- North America
- Asia Pacific
- Latin America
- Middle East & Africa
Order Full Report @ https://www.fortunebusinessinsights.com/checkout-page/100065
“Technological Advancements in Products to Enable Market Growth”
Coronary stents allow minimally invasive surgical procedures, thereby leading to a huge uptake among end users, globally. Surgical procedures using coronary stents are carried out in a much shorter time and with less discomfort than the procedures such as coronary bypass surgeries. The aforementioned factors will contribute to the growth of the global market and will enable the increase in the global coronary stents industry value in the forthcoming years.
The Resolute Onyx 2.0 was a new drug eluting stent which was introduced as the smallest stent available in the market at the time of its launch. Fortune Business Insights predicts that increasing the introduction of technologically advanced products will favor the growth of the global market in the coming years.
Recent product advancements have created a rising uptake of coronary stents in heart-related surgical procedures. In 2018, Medtronic launched a new 2 mm coronary stent for small vessels. The company also announced that it has received approval from the Food and Drug Administration (FDA) or the usage of its latest product.
“More Trending Topics from Fortune Business Insights”